SERVICES AGREEMENT BETWEEN TAXUS CARDIUM PHARMACEUTICALS GROUP, INC & ANGIONETICS INC.Services Agreement • July 11th, 2016 • Taxus Cardium Pharmaceuticals Group Inc. • Biological products, (no disgnostic substances) • Delaware
This Services Agreement (“Agreement”) dated June 6, 2016 is made and entered into by and between Taxus Cardium Pharmaceuticals Group Inc., a Delaware corporation (“Cardium”), and Angionetics Inc., a Delaware corporation and a wholly owned subsidiary of Cardium (“Angionetics”), with respect to the following facts:
SHARE PURCHASE AGREEMENT BY AND AMONG TAXUS CARDIUM PHARMACEUTICALS GROUP, INC., ANGIONETICS, INC. AND PINEWORLD CAPITAL LIMITED Dated as of June 7, 2016Share Purchase Agreement • July 11th, 2016 • Taxus Cardium Pharmaceuticals Group Inc. • Biological products, (no disgnostic substances) • California
THIS SHARE PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of June 7, 2016, by and among Taxus Cardium Pharmaceuticals Group, Inc., a Delaware corporation (“Cardium”), Angionetics, Inc., a Delaware corporation (“Angionetics”) and Pineworld Capital Limited, a Hong Kong limited liability company ( “Investor”), with respect to the following facts:.
CONTRIBUTION AGREEMENT BETWEEN TAXUS CARDIUM PHARMACEUTICALS GROUP & ANGIONETICS INC.Contribution Agreement • July 11th, 2016 • Taxus Cardium Pharmaceuticals Group Inc. • Biological products, (no disgnostic substances) • Delaware
This Contribution Agreement (the “Agreement”), is made and entered into as of June 6, 2016, by and between Taxus Cardium Pharmaceuticals Group, Inc., a Delaware corporation (“Cardium”), and Angionetics, Inc., a Delaware corporation and a wholly owned subsidiary of Cardium (“Angionetics”) with respect to the following facts:
